Roflumilast is used in people with severe chronic obstructive pulmonary disease (COPD; a group of diseases that affect the lungs and airways) to reduce the number of episodes or worsening of COPD symptoms. Roflumilast is in a class of medications called phosphodiesterase inhibitors. It works by decreasing swelling in the lungs.



DAXAS (roflumilast) administered once daily (500 mcg tablet per day) is indicated, as add-on

therapy to bronchodilator treatment, for the maintenance treatment of severe chronic obstructive

pulmonary disease (COPD) associated with chronic bronchitis (i.e. patients with a history of

chronic cough and sputum) in adult patients with a history of frequent exacerbations.



Our European Brand Name product information:



DAXAS (roflumilast) film-coated tablets, 500 mcg

• Quanity:90 Tabs
• Strength: 500mcg